A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse Kidney Events (MAKE) - Clinical Trial NCTNCT06602453

Business Opportunities for NCT06602453

Connect with principal investigators, study coordinators, and key decision makers for this PHASE2 trial studying investigational therapy for Acute Kidney Injury, Wounds and Injuries.

Clinical Trial Information

Study Sponsor

Sponsor information available

Drug/Intervention

Study intervention details available

Therapeutic Area

Acute Kidney Injury, Wounds and Injuries

Study Phase

PHASE2

Study Status

RECRUITING

NCT Number

NCTNCT06602453

Find Contact Information

Access exclusive contact details for:

• Principal investigators and sub-investigators
• Study coordinators and research staff
• Site directors and facility contacts
• Sponsor representatives and CRO partners
• Business development professionals
• Clinical operations managers

Clinical Trial Locations

This study has 29 locations across United States, Australia, Belgium, Canada, Czechia, France, Germany, Korea, Republic of, New Zealand, Spain, United Kingdom.

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

• Discover clinical trials before competitors
• Access exclusive contact information
• Track sponsor pipelines and opportunities
• Connect with decision makers directly
• Win more business partnerships